Granlen LLC is categorized under Research and Development Laboratories in Carlsbad, CA and active since 2009.
Granlen LLC was established in 2009, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Dr Haoyun An at the company’s single location by writing to 7864 Paseo Tulipero, Carlsbad, California CA 92009 or by phoning (760) 846-6460. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Granlen LLC |
| Contact Person: | Dr Haoyun An |
| Address: | 7864 Paseo Tulipero, Carlsbad, California 92009 |
| Phone Number: | (760) 846-6460 |
| Website Address: | granlen.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Granlen LLC was started in 2009 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Dr Haoyun An for inquiries that concern Granlen LLC by calling the company number (760) 846-6460, as your correspondence is most welcome. Additionally, the physical location of the single location of Granlen LLC can be found at the coordinates 33.076268,-117.261275 as well as the street address 7864 Paseo Tulipero in Carlsbad, California 92009.
For its online presence, you may visit Granlen LLC’s website at granlen.com and engage with its social media outlets through on Twitter and on Facebook.